1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Infarction, Middle Cerebral Artery in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alvarez-Builla, J; Atkins, K; Bazan, NG; Belayev, L; Gordon, WC; Khoutorova, L | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
LAU-0901, a novel platelet-activating factor antagonist, is highly neuroprotective in cerebral ischemia.
Topics: Acute Disease; Animals; Behavior, Animal; Brain Ischemia; Cerebrovascular Circulation; Dihydropyridines; Dose-Response Relationship, Drug; Infarction, Middle Cerebral Artery; Male; Mice; Mice, Inbred C57BL; Neocortex; Neuroprotective Agents; Platelet Activating Factor; Rats; Rats, Sprague-Dawley | 2008 |